Oregovomab
Based on 1 Customer Validation
Oregovomab (Alt-2 monoclonal antibody) is a murine mAb targeting CA125. Oregovomab induces cytotoxic immune response against CA125 expressing tumor cells.
For research use only. We do not sell to patients.
- Purity : 99.66%
- CAS No.: 213327-37-8
- Molecular Weight:146.72 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
MUC16
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 213327-37-8
-
Appearance Liquid
-
Molecular Weight 146.72 kDa
-
Color Colorless to light yellow
-
SMILES
[Oregovomab]
-
Synonyms
Alt-2 monoclonal antibody; MAB-B43.13; Oregovamab
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Pietragalla A, et al. Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opin Investig Drugs. 2021 Feb;30(2):103-110. [Content Brief]
[2]. Sparholt MH, et al. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? APMIS. 2013 Jan;121(1):38-44. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)